Back to results
US 2013/0156823 A1Published application
Excipient-free Aerosol Formulation
AssigneeMAP Pharmacauticals, Inc.
InventorsLibo WU, Wiwik Watanabe
Life of this patent
Estimating the term…
Abstract
Methods and compositions for producing formulations for orally inhaled benzodiazepines that do not require the presence of a surface modifier are described. The formulations are useful in the treatment of epileptic seizures.
Claims11
A pharmaceutical aerosol formulation comprising:
- (i) a particulate benzodiazepine;
- and (ii) a propellant, wherein the aerosol formulation does not contain a surfactant or other surface modifiers.
A pharmaceutical aerosol formulation consisting of a particulate benzodiazepine and a propellant, wherein the aerosol formulation is stable at 25° C. and 60% relative humidity (RH) conditions for at least 4 weeks.
Dependencies are inferred from the claim text.